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I M M U N O L O G Y
Functionally distinct resident macrophage subsets 
differentially shape responses to infection 
in the bladder
Livia Lacerda Mariano1,2, Matthieu Rousseau1,2, Hugo Varet3,4, Rachel Legendre3,4, 
Rebecca Gentek5*, Javier Saenz Coronilla6, Marc Bajenoff5,  
Elisa Gomez Perdiguero6, Molly A. Ingersoll1,2†
Resident macrophages are abundant in the bladder, playing key roles in immunity to uropathogens. Yet, whether 
they are heterogeneous, where they come from, and how they respond to infection remain largely unknown. We 
identified two macrophage subsets in mouse bladders, MacM in muscle and MacL in the lamina propria, each with 
distinct protein expression and transcriptomes. Using a urinary tract infection model, we validated our transcriptomic 
analyses, finding that MacM macrophages phagocytosed more bacteria and polarized to an anti-inflammatory profile, 
whereas MacL macrophages died rapidly during infection. During resolution, monocyte-derived cells contrib-
uted to tissue-resident macrophage pools and both subsets acquired transcriptional profiles distinct from naïve 
macrophages. Macrophage depletion resulted in the induction of a type 1–biased immune response to a second 
urinary tract infection, improving bacterial clearance. Our study uncovers the biology of resident macrophages 
and their responses to an exceedingly common infection in a largely overlooked organ, the bladder.
INTRODUCTION
Tissue-resident macrophages regulate immunity and are pivotal for 
development, homeostasis, and repair (1). Major research efforts 
have uncovered roles for tissue-resident macrophages during infec-
tion, insult, and repair. However, in many cases, these studies dis-
proportionally focus on certain organs in animals while disregarding 
tissue macrophages in other locations (2). Because function in mac-
rophages is shaped by their tissue of residence and the local envi-
ronment, specific phenotypes may not be universally applicable to 
all tissues (3). Notably, the bladder has generally been overlooked 
in macrophage studies; consequently, the function, origin, and re-
newal of bladder-resident macrophages in health and disease are 
poorly characterized or even completely unknown (4, 5).
Tissue-resident macrophages in adult organisms originate from 
embryonic progenitors, adult bone marrow (BM), or a mixture of 
both (6–12). During development, hematopoiesis begins in the yolk 
sac, giving rise to erythrocytes and macrophages directly and to 
erythro-myeloid progenitors (EMPs) (6, 13, 14). As hematopoiesis 
declines in the yolk sac, an intraembryonic wave of definitive hema-
topoiesis begins in the aorta-gonad-mesonephro, generating 
hematopoietic stem cells (HSCs). EMPs and then HSCs colonize 
the fetal liver to give rise to fetal liver monocytes, macrophages, and 
other immune cells, whereas only HSCs migrate to the BM to establish 
hematopoiesis in postnatal animals (15). Embryo-derived macro-
phages can either self-maintain and persist into adulthood or 
undergo replacement by circulating monocytes at tissue-specific 
rates. For example, a majority of macrophages in the gut are con-
tinuously replenished by BM-derived cells, whereas brain macro-
phages, or microglia, are long-lived yolk sac–derived cells that are 
not replaced in steady-state conditions (8, 14, 16, 17). In certain 
conditions, origin influences macrophage behavior; for example, 
following myocardial infarction, embryonic-derived cardiac macro-
phages promote tissue repair, whereas BM-derived macrophages 
induce inflammation (18). However, macrophage functions are 
also imprinted by their microenvironment (19, 20). In the small 
intestine, macrophages in the muscle express higher levels of tissue- 
protective genes, such as Retnla, Mrc1, and Cd163 compared to lamina 
propria macrophages, although both originate from adult BM (21).
While the origin and maintenance of bladder-resident macro-
phages are currently unknown, these macrophages do play a role in 
response to urinary tract infection (UTI), which affects up to 50% of 
all women at some point in their lifetimes (5, 22). The immune 
response to uropathogenic Escherichia coli (UPEC) infection in the 
bladder is characterized by robust cytokine expression leading to 
rapid infiltration of large numbers of neutrophils and classical 
Ly6C+ monocytes (23–28). Although essential to bacterial clearance, 
neutrophil and monocyte infiltration likely also induce collateral 
tissue damage. Targeted depletion of one of these two cell types is 
associated with reduced bacterial burden after primary infection 
in mice, whereas elimination of both cell types together leads to 
unchecked bacteria growth (23, 25, 26). Tissue-resident macrophages 
also take up a large number of bacteria during UTI; however, deple-
tion of resident macrophages just before infection does not change 
bacterial clearance in a first or primary UTI (23). The absence of 
macrophages in the early stages of a primary UTI significantly 
improves bacterial clearance during a second, or challenge, infection 
(23). Exactly how the elimination of resident macrophages im-
proves the response to a challenge infection is unclear, particularly 
as tissue-associated macrophages return to homeostatic numbers 
in the time interval between the two infections. Of note, improved 
bacterial clearance is lost in macrophage-depleted mice that are also 
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depleted of CD4+ and CD8+ T cells, suggesting that macrophages 
modulate T cell activation or limit differentiation of memory 
T cells, as observed in other tissues (29–33). For example, ablation 
of embryonic-derived alveolar macrophages results in increased 
numbers of CD8+ resident memory T cells following influenza 
infection in mice (31). In the gut, monocyte-derived macrophages 
support the differentiation of CD8+ tissue-resident memory T cells 
by production of interferon- (IFN-) and interleukin-12 (IL-12) 
during Yersinia infection (32). The opposing roles of macrophages 
in modulating T cell responses in the lung and gut support the idea 
that tissue type and/or ontogeny determines how macrophages may 
influence adaptive immunity (13).
To understand the role of bladder-resident macrophages, we in-
vestigated the origin, localization, and function of these cells during 
infection. We identified two subpopulations of resident macro-
phages in naïve mouse bladders with distinctive cell surface pro-
teins, spatial distribution, and gene expression profiles. We found 
that bladder macrophage subsets were long-lived cells, slowly re-
placed by BM-derived monocytes over the lifetime of the mouse. 
During UTI, the macrophage subsets differed in their capacity to 
take up bacteria and survive infection; however, both subsets were 
replaced by BM-derived cells following resolution of infection. 
Thus, after a first infection, macrophage subsets had divergent tran-
scriptional profiles compared to their naïve counterparts, shaping 
the response to subsequent UTI.
RESULTS
Two spatially distinct macrophage populations reside 
in the naïve bladder
We reported that macrophage depletion before a first UTI improves 
bacterial clearance during challenge infection (23). Thus, we initiat-
ed a follow-up study to investigate the role of bladder-resident mac-
rophages during UTI. Using the macrophage-associated cell surface 
proteins CD64 and F4/80 (34, 35), we identified a clear CD64 and 
F4/80 double-positive resident macrophage population in naïve 
bladders from 7- to 8-week-old female CX3CR1GFP/+ mice. This 
transgenic mouse is widely used to distinguish macrophage popula-
tions in other tissues as the chemokine receptor CX3CR1 is ex-
pressed by monocytes and macrophages at some point in their 
development (36). In most tissues, resident macrophages are either 
GFP+ as they express CX3CR1 or GFP− because they no longer 
express CX3CR1 (10). Therefore, we were surprised to observe hetero-
geneity in green fluorescent protein (GFP) expression levels, reveal-
ing potentially two subpopulations (Maclo and Machi) of CD64+ 
F4/80+ macrophages in the bladder (Fig. 1A). Although the differ-
ences were small in magnitude, the Machi-expressing population 
was present in statistically significantly greater numbers and pro-
portions compared to the Maclo population (Fig. 1A). As CX3CR1 
deficiency results in decreased macrophage numbers and frequency 
in the intestine and brain, and the transgenic CX3CR1GFP/+ mouse 
we used is hemizygous for this receptor (36–38), we investigated 
whether our putative bladder-resident macrophage subsets were 
similarly present in wild-type C57BL/6 mice. Using the same gating 
strategy and an anti-CX3CR1 antibody, we clearly identified that 
CX3CR1 expression levels distinguished two distinct macrophage 
populations in 7- to 8-week-old naïve female wild-type mice (Fig. 1B). 
Notably, wild-type mice had similar numbers and proportions of 
each macrophage subset (Fig. 1B).
Next, we assessed the surface expression level of proteins known 
to define macrophage subsets in other tissues (39). We observed 
that the efferocytic receptor TIM4 and hyaluronan receptor LYVE1 
were expressed by the Maclo population, whereas the Machi popula-
tion was TIM4– and LYVE1– (Fig. 1C). Macrophage-associated 
proteins, such as CD64, F4/80, CD11b, CD11c, and MHC II, were 
differentially expressed between the subsets (fig. S1A), supporting 
the notion that these are distinct populations. A recent publication 
described several organs as having two distinct macrophage subsets, 
differentiated by their expression of LYVE1, CX3CR1, and, in par-
ticular, MHC II (39). To determine whether bladder macrophage 
subsets represented these two cell types, we used a similar gating 
strategy (fig. S1B); however, we observed that MHC II− CD64+F4/80+ 
cells made up a very minor proportion (<2%) of bladder-resident 
macrophages (fig. SC). Last, to determine whether additional het-
erogeneity existed within the CD64+ F4/80+ bladder-resident 
macrophage population, we used the dimension reduction analyses 
tSNE and UMAP to visualize our data. In our analyses of the naïve 
CD45+ cell population, a large CD64+ cluster contained two putative 
subsets that corresponded to traditionally gated Maclo and Machi 
populations and included the tiny proportion of MHC II− macro-
phages (fig. S1D). tSNE (t-distributed stochastic neighbor embedding) 
and, more particularly, UMAP (uniform manifold approximation and 
projection) analysis of CD64+ F4/80+ macrophages revealed two 
groups, with differential expression of CX3CR1, F4/80, CD64, LYVE1, 
and TIM4, reflecting the data shown in the traditionally gated histo-
grams (fig. S1, D and E). Thus, we concluded that two subsets of 
macrophages reside in naïve mouse bladders with differential surface 
protein expression.
To determine the spatial orientation of the subsets, we stained 
naïve female C57BL/6 bladders with antibodies to F4/80 and LYVE1 
and phalloidin to demarcate the muscle layer from the lamina pro-
pria (Fig. 1D). We quantified the number of each subset in these 
two anatomical locations, observing a higher percentage of the 
LYVE1+ Maclo macrophage subset in the muscle compared to 
the LYVE1− Machi macrophage subset (Fig. 1E). Macrophages 
in the lamina propria were predominantly of the Machi phenotype 
(Fig. 1E). Thus, the phenotypic differences we observed in bladder- 
resident macrophage subsets extended to differential tissue local-
ization. Given their spatial organization, we renamed the Maclo 
subset “MacM” for muscle and the Machi subset “MacL” for lamina 
propria. Together, these results reveal that two phenotypically 
distinct macrophage subsets reside in different regions of the naïve 
bladder.
Bladder-resident macrophages are replaced by HSC-derived 
macrophages after birth
We next investigated whether macrophage heterogeneity in adult 
mouse bladders arose due to distinct developmental origins of 
the subsets. We analyzed bladders from newborn C57BL/6 pups 
by confocal imaging and by flow cytometry from CX3CR1-GFP– 
expressing E16.5 (embryonic day 16.5) embryos and newborn mice. 
We observed that, in E16.5 and newborn animals, a single CX3CR1hi 
macrophage population was present in the muscle and lamina pro-
pria of the bladder. By flow cytometry, these cells were uniformly 
positive for CD64 and negative for MHC II as expected for fetal 
macrophages (40) and stained positively for LYVE1 in confocal im-
ages of newborn mouse bladder, supporting that diversification of 
bladder macrophage subsets occurs after birth (Fig. 2A).
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Fig. 1. Two macrophage subsets are resident in adult naïve mouse bladders. (A to C) Bladders from 7-week-old female CX3CR1GFP/+ and C57BL6/J mice were analyzed 
by flow cytometry. (A and B) Dot plots depict the gating strategy for macrophages subsets and graphs show the total cell number (log scale, left) and proportion (right) 
of bladder macrophage subset, derived from cytometric analysis in (A) CX3CR1GFP/+ and (B) C57BL6/J mice. (C) Histograms show the relative expression of CX3CR1, TIM4, 
and LYVE1 on macrophage subsets in C57BL6/J mice, Maclo is green and Machi is orange. (See fig. S1 for data on expression of additional proteins). (D) Representative 
confocal images of bladders from C57BL6/J mice at 20× and 40×. Merged images and single channels with the target of interest are shown. DAPI, 4′,6-diamidino- 2-
phenylindole. (E) Graphs show the proportion of each macrophage subset in the lamina propria and muscle of naïve C57BL6/J mice. Data are pooled from three experi-
ments, n = 3 to 6 mice per experiment. Each dot represents one mouse; lines are medians. Significance was determined using the nonparametric Mann-Whitney test to 
compare macrophage subset numbers (A and B) and the nonparametric Wilcoxon matched-pairs signed-rank test to compare the macrophage subset percentages (A, B, and 
E). All P values are shown; statistically significant P values (<0.05) are in red.
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Fig. 2. Bladder-resident macrophages are long-lived HSC-derived cells. (A) Merged confocal and single channel images from a C57BL/6 newborn mouse bladder. Left 
image is enlarged at the right. Gating strategy in Cdh5-CreERT2Rosa26tdTomato CX3CR1GFP newborn mice and E16.5 embryos; histograms show CX3CR1 and MHC II expression. 
(B to E) Reporter recombination in microglia, monocytes, bladder macrophages, and MacM and MacL subsets in Cdh5-CreERT2Rosa26tdTomato mice: (B) E16.5 embryos, 
newborns 4-hydroxytamoxifen (4OHT)-treated at E7.5, (C) adults 4OHT-treated at E7.5, (D) E16.5 embryos, newborns 4OHT-treated at E10.5, (E) adults 4OHT-treated at E10.5. 
(F) Percentage of YFP+ cells in microglia, monocytes, MacM, and MacL macrophages in adult Flt3CreRosa26YFP mice. (G to I) Adult shield-irradiated C57BL/6 CD45.2 mice 
reconstituted with CCR2+/+ CD45.1 BM and C57BL/6 CD45.1 mice reconstituted with CCR2−/− CD45.2 BM. Percentage of donor cells (G) in monocytes or (H) bladder-resident 
macrophages in mice transplanted with CCR2+/+ or CCR2−/− BM at 3 and 6 months after transplantation. (See fig. S2 for data on blood leukocyte chimerism). (I) Bladder- 
resident macrophage replacement rate. Data pooled from two to three experiments, n = 2 to 6 mice per experiment. Each point represents one mouse; lines are medians. 
Significance determined using the Mann-Whitney test comparing (B to F) macrophages or subsets to monocytes or (G and H) CCR2+/+ to CCR2−/− recipients, P values were 
corrected for multiple testing using the false discovery rate (FDR) method. All P values are shown; statistically significant P values (<0.05) are in red.
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We hypothesized that, in adult mice, macrophage subsets arise 
following differentiation of cells seeded from embryonic progeni-
tors or that one subset is derived from embryonic macrophages, 
whereas the second subset arises from BM-derived monocytes (41). 
To test these hypotheses, we used the Cdh5-CreERT2 Rosa26tdTomato 
transgenic mouse, in which the contribution of distinct hemato-
poietic progenitor waves to immune cell populations can be 
followed temporally, such that treatment of pregnant mice with 
4-hydroxytamoxifen (4OHT) at E7.5 labels yolk sac progenitors 
and their progeny and treatment at E10.5 labels HSC that will settle 
in the BM (adult-type HSCs) and their cellular output (42). After 
treatment with 4OHT at E7.5, in which microglia were labeled as 
expected (8, 14), we found a significantly higher proportion of 
labeled bladder macrophages compared to monocytes in E16.5 
embryos and newborn mice (Fig. 2B). Labeled bladder macrophage 
subsets were nearly absent, similar to monocytes, in adult (8- to 
11-week-old) mice (Fig. 2C). These data support the fact that yolk 
sac–derived bladder macrophages are diluted after birth in the adult 
and suggest that the subsets are composed of HSC-derived macro-
phages. Low levels of E10.5-labeled macrophages were detected 
in embryonic bladders (Fig. 2D), and their frequency increased in 
newborn and adult mice, although to a lesser degree than mono-
cytes, supporting the idea that bladder macrophage subsets arise, at 
least in part, from adult-type HSCs (Fig. 2, D and E). Of note, both 
subsets found in the adult bladder showed similar frequencies of 
E10.5 labeling (Fig.  2E). Together, these results demonstrate that 
adult bladder macrophages are partially HSC-derived and the mac-
rophage subsets cannot be distinguished from each other by their 
ontogeny.
To confirm that HSC-derived progenitors contribute to the 
bladder-resident macrophage pool, we analyzed bladders from 
adult Flt3Cre Rosa26YFP mice. In this transgenic mouse, expression 
of the tyrosine kinase receptor Flt3 in multipotent progenitors leads 
to expression of yellow fluorescent protein (YFP) in the progeny of 
these cells, such as monocytes, whereas microglia, arising from yolk 
sac progenitors, are essentially YFP− (43). Recombination rates 
driven by Flt3 are very low during embryonic development, but 
blood monocyte labeling reaches 80 to 90% in adult mice (7). Therefore, 
if tissue-resident macrophages arise from postnatal BM-derived 
monocytes, labeling in adult mice should be similar to blood mono-
cytes, whereas the presence of Flt3− tissue macrophages would 
indicate that they originated from either embryonic HSCs or adult 
Flt3-independent progenitors. We observed that, in 2- to 4-month-old 
and 22- to 24-month-old mice, ~50% of each macrophage subset 
was YFP+, which was significantly lower compared to circulating 
monocytes (Fig. 2F). This observation and those from the Cdh5-
CreERT2 mice together support the fact that, in addition to adult 
HSCs, adult bladder macrophage subsets are derived from embryonic 
progenitors that may include fetal HSCs, and/or later yolk sac pro-
genitors, but with no contribution from early yolk sac progenitors. 
In addition, the lack of equilibration of YFP labeling in the bladder 
with blood monocytes at 22 to 24 months suggests that tissue mac-
rophages are not rapidly replaced over the lifetime of the mouse by 
BM-derived cells in the context of homeostasis.
To determine the replacement rate of bladder-resident macro-
phages by BM-derived cells in the adult mouse, we evaluated shielded 
irradiated mice, in which adult animals are irradiated with a lead 
cover over the bladder to protect this organ from radiation-induced 
immune cell death and nonhomeostatic immune cell infiltration. 
Animals were transplanted with congenic BM from wild-type or 
CCR2−/− mice. Monocytes depend on CCR2 receptor signaling to 
exit the BM into circulation (44). At 3 and 6 months, we observed 
that a median of 27.7% (3 months) and 27.6% (6 months) of circu-
lating Ly6C+ monocytes were of donor origin in mice reconstituted 
with wild-type BM, which is well in-line with published studies 
using this approach (45, 46), whereas only 6.1% (3 months) and 6.5% 
(6 months) of Ly6C+ monocytes were of donor origin in wild-type 
mice receiving CCR2−/− BM (Fig.  2G). B and natural killer (NK) 
cells were replenished to a greater extent in mice reconstituted with 
CCR2−/− BM compared to mice reconstituted with CCR2+/+ BM, 
which could be due to different engraftment efficiencies between 
CD45.1 and CD45.2 BM (fig. S2) (47,  48). In mice reconstituted 
with wild-type BM, 4.7% of MacM and 4.5% MacL were of donor 
origin at 3 months after engraftment. At 6 months after irradiation, 
7% of MacM and 8.5% of MacL macrophages were of donor origin 
(Fig. 2H). Chimerism in bladder macrophage subsets was markedly 
reduced in CCR2−/− BM recipients, suggesting that monocytes 
slowly replace bladder macrophage subsets in a CCR2-dependent 
manner (Fig. 2H). By dividing the median macrophage subset 
chimerism (7 or 8.5%) by the median circulating Ly6C+ monocyte 
chimerism at 6 months in mice receiving wild-type BM (27.6%), we 
determined that 25.3% of MacM and 30.8% MacL were replaced by 
BM-derived monocytes within 6 months (Fig. 2I).
Together, these results reveal that the establishment of distinct 
bladder-resident macrophage subsets occurs postnatally. Yolk sac 
macrophages initially seed the fetal bladder but are replaced by fetal 
HSC-derived macrophages. In adult mice, bladder macrophage 
subsets are partially maintained through a slow replacement by 
BM-derived monocytes, although a substantial number of fetally 
derived cells remain. The incomplete macrophage labeling we 
observed in our experiments supports the idea that a progenitor 
source, which cannot be labeled in either model, contributes to 
resident bladder macrophages. Currently, there is no fate-mapping 
model to discriminate or follow progeny specifically from late 
yolk sac EMPs or early fetally restricted HSC, as hematopoietic 
waves overlap in development. We can conclude that MacM and 
MacL macrophages do not differ in their developmental origin or 
rate of replacement by monocytes, supporting the view that one or 
more unique niches in adult tissue may be responsible for macro-
phage specialization into phenotypical and functionally distinct 
macrophage subsets.
Bladder-resident macrophage subsets have  
divergent transcriptomes
Although bladder-resident macrophage subsets had similar ontogeny, 
their distinct spatial localization and surface protein expression 
suggested that they have different functions. To test this hypothesis, 
we first analyzed gene expression profiles of naïve adult female 
MacM and MacL macrophages using bulk RNA sequencing (RNA-
seq) (fig. S3A, gating strategy). To formally demonstrate that our 
cells of interest are macrophages, we aligned the transcriptomes of 
the bladder macrophage subsets with the macrophage core signa-
ture list published by the Immunological Genome Consortium and 
the bladder macrophage core list from the mouse cell atlas single- 
cell database (35, 49). The MacM and MacL subsets expressed 
80% of the genes from the Immunological Genome Consortium 
macrophage core signature list and more than 95% of the genes 
in the bladder macrophage core list (fig. S3B), supporting the idea 
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that our cells of interest are fully differentiated tissue-resident 
macrophages.
We observed that 1475 genes were differentially expressed be-
tween naïve MacM and MacL macrophages, in which 899 genes 
were positively regulated and 576 genes were negatively regulated in 
the MacL subset relative to MacM macrophages (Fig. 3A). In the 
top 20 differentially expressed genes (DEG), MacM macrophages 
expressed higher levels of Tfrc, Ms4a8a, Serpinb6a, CCL24, Scl40a1, 
Clec10a, and Retnla, all of which are associated with an alternatively 
activated macrophage phenotype (50–53); genes involved in iron 
metabolism, such as Tfrc, Steap4, and Slc40a1 (54); and genes from 
the complement cascade, including C4b and Cfp (Fig. 3B). In the 
same 20 most DEG, MacL macrophages expressed greater levels 
of Cx3cr1, Cd72, Itgb5, Axl, and Itgav, which are associated with 
phagocytosis, antigen presentation, and immune response activa-
tion (Fig. 3B) (55–57). MacL macrophages also expressed inflam-
matory genes, such as Cxcl16, a chemoattractant for T and NKT 
cells (58, 59), and Lpcat2 and Pdgfb, which are involved in the 
metabolism of inflammatory lipid mediators (Fig. 3B) (60, 61). Using 
gene set enrichment analysis of the DEG to detect pathways up- 
regulated in the macrophage subsets, we observed that the MacM subset 
expressed genes linked to pathways such as endocytosis, mineral 
absorption, lysosome, and phagosome (Fig. 3C). Within the phago-
some and endocytosis pathways, genes critical for bacterial sensing 
and alternative activation such as Tlr4, Mrc1 (encoding for CD206), 
Cd209, and Egfr (62–64) were increased in the MacM subset. In the 
mineral absorption pathway, genes controlling iron metabolism 
that also enhance bacterial killing such as Hmox1 and Hmox2 were 
up-regulated in MacM macrophages (Fig. 3D) (65). In the MacL 
subset, genes linked to diverse inflammatory pathways, including 
Toll-like receptor signaling, apoptosis, antigen processing and presentation, 
and chemokine signaling, were present, as were many infectious 
and inflammatory disease–related pathways (Fig. 3E). Within these 
pathways, the MacL subset expressed genes related to bacterial 
sensing, such as Tlr1, Tlr2, and Cd14; initiation of inflammation, 
such as Il1b, Tnf, Ccl3, Ccl4, Cxcl10, Cxcl16, and Nfkb1; and apop-
totic cell death, such as Mapk8, Pmaip1, Bcla1d, Cflar, Bcl2l11, and 
Birc2 (Fig. 3F).
These findings suggest that MacM macrophages are more anti- 
inflammatory with increased endocytic activity, which is a common 
feature of highly phagocytic resident macrophages (66), and as such 
may play a prominent role in bacterial uptake or killing during in-
fection. MacL, on the other hand, may play a greater role in antigen 
presentation and initiation or maintenance of inflammation.
Macrophage subsets respond differently to infection
As we observed enrichment of genes belonging to endocytosis, 
lysosome, and phagosome pathways in the MacM subset, we reasoned 
that the macrophage subsets differentially take up bacteria during 
infection. To test our hypothesis, we used a well-described mouse 
model of UTI, in which we transurethrally infect adult female mice 
via catheterization with 107 colony-forming units (CFU) of UPEC 
strain UTI89-RFP, which expresses a red fluorescent protein (RFP) 
(23). At 24 hours post-infection (PI), we investigated bacterial up-
take by macrophage subsets (Fig. 4, A and B). Despite that MacM 
macrophages are farther from the infected urothelium than MacL 
macrophages, we observed that 20% of MacM and only 10% of 
MacL subsets contained bacteria at 24 hours PI, providing func-
tional evidence to support the transcriptional data that MacM 
macrophages have a superior phagocytic capacity compared to 
MacL macrophages (Fig. 4B). Supporting this conclusion, we found 
that when we exposed sorted MacM and MacL macrophages to live 
UPEC in vitro, a greater proportion of MacM macrophages inter-
nalized bacteria after 2 hours compared to MacL macrophages 
(fig. S4A). In addition, despite very low levels of infection overall 
(~1% of macrophages), more UPEC could be found in MacM mac-
rophages compared to MacL macrophages at 4 hours PI in vivo 
(fig. S4B). Taking the total population of UPEC-containing macro-
phages at 24 hours PI, we observed that ~80% of these cells were 
MacM macrophages, whereas the MacL subset comprised only 20% 
of this population, which was unusual given that MacM and 
MacL exist in the bladder in a 1:1 ratio (Fig. 4B and fig. S4C, gating 
strategy).
Given the predominance of genes associated with alternatively 
activated macrophages in the top 20 DEGs of MacM macrophages 
(Fig. 3B), we measured polarization of the macrophage subsets in 
naïve and infected bladders by analyzing the expression of IL-4R 
by flow cytometry (Fig. 4C). IL-4R is the receptor of IL-4 and 
IL-13, two cytokines that drive alternative activation in macrophages 
(67). Both subsets had increased expression of IL-4R at 24 hours 
PI compared to their naïve counterparts; however, MacM macro-
phages had consistently higher expression levels of IL-4R com-
pared to MacL macrophages in naïve and infected tissue (Fig. 4C).
In the course of our studies, we observed that the total number 
and proportion of MacL macrophages were significantly lower than 
those of MacM macrophages at 24 hours PI, whereas, in naïve mice, 
both the number and proportion of the macrophage subsets were 
equivalent (Figs. 4D and 1B). To rule out the contribution of differ-
entiated monocyte-derived cells to the macrophage pool, we as-
sessed total macrophage cell numbers in the bladder at 4 hours PI, 
when there is minimal monocyte infiltration (Fig. 4E) (23). Macro-
phage subset numbers and proportions were significantly different 
at 4 hours PI (Fig. 4F). As the total numbers of each subset were not 
increased over naïve levels (Fig. 1B), we hypothesized that macro-
phages die during infection, particularly as apoptosis pathways 
were more highly expressed in MacL macrophages (Fig. 3, C and D). 
Using a cell viability dye, which labels dying/dead cells, we found 
that a significantly higher proportion of MacL macrophages were 
dying compared to MacM macrophages at 4 hours PI (Fig. 4G and 
fig. S4D, gating strategy). As UPEC strains can induce macrophage 
death in vitro (68, 69), we asked whether macrophage cell death was 
induced by UPEC in vivo. We observed that only 20% of dying or 
dead cells in each subset were infected (Fig. 4H), suggesting that 
macrophage death was not primarily driven by UPEC uptake. To 
determine whether macrophage cell death was confined to a dis-
tinct location, we quantified macrophage subset numbers in the 
muscle and lamina propria. We observed that, at 4 hours PI, only 
MacL macrophages located in the lamina propria were reduced in 
numbers compared to naïve mice (Fig. 4I). Given that, in the first 
hours after infection, the urothelium exfoliates massively (70), these 
results suggest that macrophage death, specifically in the lamina 
propria, may be due to the loss of a survival factor in this niche. To 
test whether alteration of the niche induced macrophage death, we 
chemically induced global urothelial exfoliation by intravesical in-
stillation of protamine sulfate (71, 72). We observed that at 5 hours 
after treatment, the total numbers of both MacM and MacL subsets 
were reduced compared to macrophage subsets in naïve mice 
(fig. S4E), suggesting that alterations in bladder urothelium are 
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Fig. 3. Naïve macrophage subsets have different transcriptional programs in the naïve bladder. MacM and MacL macrophages were sorted from 7- to 
8-week-old female naïve adult C57BL/6 mouse bladders and analyzed by RNA-seq (fig. S3, gating strategy). (A) Heatmaps show the gene expression profile of the 
1475 differentially expressed genes and (B) the 20 most differentially expressed genes between the MacM and MacL subsets. (C to F) Using Kyoto Encyclopedia of 
Genes and Genomes (KEGG) pathway analysis of significantly up-regulated genes, the following are depicted: (C) pathways enriched in MacM macrophages, (D) 
up-regulated genes associated with selected pathways in MacM macrophages, (E) pathways enriched in MacL macrophages, and (F) up-regulated genes associated 
with selected pathways in MacL macrophages. In (C) and (E), the size of the nodes reflects the statistical significance of the term. (Q < 0.05; terms > 3 genes; % 
genes/term > 3;  0.4).
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Fig. 4. Macrophage subsets have divergent roles in UTI. (A to H) Female C57BL6/J mice were infected with UTI89-RFP and bladders were analyzed by flow cytometry 
at (A to D) 24 hours or (E to H) 4 hours PI. (A) Gating strategy, resident macrophage subsets, and cells containing bacteria. (B) Percentage of infected macrophage subsets 
and UPEC distribution (fig. S4B, gating strategy). (C) IL-4R gMFI (geometric mean fluorescence intensity) in naïve mice and 24 hours PI. (D) Total number and frequency 
of bladder macrophage subsets. (E) Gating strategy. (F) Total number and frequency of bladder macrophage subsets. Percentage of (G) macrophage subsets labeled with 
a live/dead marker (fig. S4D, gating strategy) and (H) dying macrophages containing UPEC. (I) MacM and MacL macrophage quantification in naïve mice and 4 hours PI. 
(B to D and F to H) Data pooled from three experiments, n = 3 to 6 mice per experiment. (I) Data are pooled from two experiments, n = 2 to 3 mice per experiment. Each 
dot represents one mouse; lines are medians. In (D) and (F), Mann-Whitney test was used to compare the numbers and the nonparametric Wilcoxon matched-pairs signed-
rank test was used to compare the percentages of each macrophage subset. (B and C and G to I) Mann-Whitney test. P values were corrected for multiple testing using 
the FDR method. All P values are shown; statistically significant P values (<0.05) are in red.
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sufficient to reduce resident macrophage numbers in the bladder, 
although protamine sulfate may also directly induce macrophage 
death. Thus, we functionally validated the divergent gene expres-
sion observed between macrophage subsets, in which MacM mac-
rophages are more phagocytic and MacL macrophages are more 
prone to die, supporting the idea that gene expression differences 
translate to divergent roles for the subsets in response to UTI.
Monocyte-derived macrophages replace resident 
macrophage subsets after infection
As we observed macrophages dying during infection, we investigated 
the change in macrophage numbers over time as animals resolved 
their infection. Both populations significantly decreased at 24 hours 
PI, then subsequently increased nearly 10-fold at 7 days PI, and 
returned to numbers just above homeostatic levels at 4 weeks PI 
(Fig. 5A). With the dynamic increase of macrophage numbers over 
the course of UTI, we hypothesized that infiltrating monocytes re-
place resident macrophage subsets during infection, as we previously 
reported that infiltrating monocytes differentiate to cells resem-
bling macrophages at 48 hours PI (23). To test this hypothesis, we 
used the CCR2CreERT2 Rosa26tdTomato mouse, in which administration 
of 4OHT induces recombination in CCR2-expressing cells, such as 
circulating Ly6C+ monocytes, leading to irreversible labeling of 
these cells in vivo (73). Blood monocytes and bladder-resident mac-
rophages are not Tomato+ in untreated mice (fig. S5). We adminis-
tered 4OHT to naïve mice and, then, 24 hours later, infected half of 
the treated mice with 107 CFU of UTI89. At this time point, 24 hours 
after 4OHT treatment, we analyzed the labeling efficiency in circu-
lating classical Ly6C+ monocytes, finding that approximately 80% 
of Ly6C+ monocytes were labeled in both naïve and infected mice 
(Fig. 5B). After 6 weeks, when animals had resolved their infection, 
there were no labeled circulating Ly6C+ monocytes in naïve or 
post-infected mice (Fig. 5B). When we analyzed the bladders of 
naïve mice 6 weeks after the 4OHT pulse, only 2.9% of MacM and 
2.1% of MacL macrophage subsets were labeled, supporting our 
earlier conclusion that monocytes contribute to bladder macro-
phage subsets at a very slow rate in the steady state (Fig. 5C). At 
6 weeks PI, the total numbers of macrophage subsets finally returned 
to homeostatic levels (Fig.  5D), but PI MacM and MacL macro-
phages had two to three times more Tomato+ cells (median, MacM 
8.4%, MacL 4.4%) than their naïve counterparts. These data support 
the fact that, after monocytes infiltrate the bladder during infection, 
they remain in the tissue following resolution, integrating themselves 
into the resident macrophage pool, and thus contribute to the return 
of macrophage subsets to homeostatic levels.
As monocytes generally have different origins and developmen-
tal programs compared to tissue-resident macrophages, we used 
RNA-seq to determine whether the macrophage pool in post- 
infected bladders was different from naïve tissue-resident cells. 
Using principal component analysis (PCA), we compared bladder 
macrophage subsets from 6-week post-infected mice to their naïve 
counterparts. We found that macrophages clustered more closely 
together by subset, rather than by infection status, or, in other 
words, naïve and post-infected MacL macrophages clustered more 
closely to each other than either sample clustered to naïve or 
post-infected MacM macrophages (Fig. 5E). Five hundred thirteen 
genes (247 genes down-regulated and 266 genes up-regulated) were 
different between naïve and post-infected MacM macrophages 
(Fig. 5F). Six hundred seventeen genes (401 genes down-regulated 
and 216 genes up-regulated) were differentially expressed between 
the naïve and post-infected MacL subset (Fig. 5G). Applying gene 
set enrichment analysis to up-regulated genes in the post-infected 
macrophage subsets, we detected common pathways between the 
subsets including enrichment of genes linked to pathways such as 
antigen presentation; cell adhesion molecules; TH1, TH2, and TH17 
cell differentiation; and chemokine signaling pathway (Fig. 5, H and I). 
Although the enriched genes were not identical within each subset 
for these pathways, some common up-regulated genes included 
those encoding for histocompatibility class 2 molecules, such as H2-
Ab1, H2-Eb1, H2-DMb1, Ciita, and the Stat1 transcription factor 
(Fig. 5, I and J). As differentiation of monocytes into macrophages 
includes up-regulation of cell adhesion and antigen presentation 
molecules (74), including in the bladder (23), these data further 
support the idea that monocytes specifically contribute to the PI 
bladder-resident macrophage pool.
These results show that, in the context of UTI, dying macro-
phages are replaced by monocyte-derived cells. Tissue-resident 
macrophage subsets maintain their separate identities distinct from 
each other after infection, although each subset also takes on a dif-
ferent transcriptional profile compared to their naïve counterparts, 
with up-regulated expression of genes related to adaptive immune 
responses.
Macrophage depletion before challenge improves 
bacterial clearance
We previously reported that macrophage depletion 24 hours before 
a primary UTI does not affect bacterial clearance (23). Given that 
post-infected macrophage subsets up-regulated pathways different 
from those associated with the transcriptomes of naïve bladder 
macrophage subsets, and that these pathways were linked to inflam-
matory diseases and the adaptive immune response, we hypothe-
sized that one or both macrophage subsets would mediate improved 
bacterial clearance to a challenge infection. To test this hypothesis, 
we infected mice with 107 CFU of kanamycin-resistant UTI89-
RFP. Four weeks later, when the infection was resolved, mice were 
challenged with 107 CFU of the isogenic ampicillin-resistant UPEC 
strain, UTI89-GFP, and bacterial burden was measured at 24 hours 
PI. To test the contribution of the macrophage subsets to the re-
sponse to challenge infection, we used different concentrations of 
anti-CSF1R depleting antibody to differently target the two macro-
phage subsets directly before challenge infection (Fig. 6A, experi-
mental scheme). Using 500 g of anti-CSF1R antibody, we depleted 
50% of MacM and 80% of MacL macrophages, whereas depletion 
following treatment with 800 g of anti-CSF1R antibody reduced 
MacM macrophages by 80% and the MacL subset by more than 
90% (Fig. 6B and fig. S6A). Twenty-four hours after anti-CSF1R an-
tibody treatment, the number of circulating neutrophils, eosino-
phils, NK, B, or T cells was not different from mock-treated mice at 
either concentration (fig. S6B). Classical Ly6C+ monocytes were 
modestly reduced in mice treated with 800 g of anti-CSF1R anti-
body but were unchanged in mice receiving 500 g of depleting an-
tibody. Antibody treatment did not change circulating nonclassical 
monocyte numbers (fig. S6B). After challenge infection, the bacterial 
burden was not different in mice treated with 500 g of anti-CSF1R 
compared to mock-treated mice (Fig. 6C). By contrast, mice depleted 
with 800 g of anti-CSF1R had reduced bacterial burdens, indica-
tive of a stronger response after challenge compared to nondepleted 
mice (Fig. 6D).
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Fig. 5. Macrophage subset transcriptional profiles are altered by UTI. (A) Total number of MacM (green) and MacL (orange) in naïve and 1-, 7-, or 28-day PI mice. 
(B and C) CCR2CreERT2Rosa26tdTomato mice were pulsed with 4OHT. Twenty-four hours later, half were infected with UTI89-RFP. Percentage of Tomato+ (B) Ly6C+ monocytes 
24 hours and 6 weeks after 4OHT-pulse or (C) bladder macrophage subsets 6 weeks after 4OHT-pulse. (D) Total number of macrophage subsets in naïve and 6-week PI 
bladders. (E) Replicate-adjusted principal component analysis of all genes from naïve and post-infected bladder macrophage subsets. Differentially expressed genes 
between naïve and 6-week PI (F) MacM (513 genes) and (G) MacL (617 genes) macrophages. KEGG pathway analysis of significantly up-regulated genes, enriched in 
6-week PI (H) MacM and (I) MacL macrophages. Up-regulated genes from selected pathways in 6-week PI (J) MacM and (K) MacL macrophages. (A, C, and D) Mann-Whitney 
test comparing infection to naïve. P values were corrected for multiple testing using the FDR method. Higher left-shifted P values refer to MacM and lower right-shifted 
P values refer to MacL. (H and I) Node size reflects statistical significance of the term (Q < 0.05; terms > 3 genes; %genes/term > 3;  0.4). All P values are shown; statistically 
significant P values (<0.05) are in red.
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Neutrophils take up a majority of UPEC at early time points 
during UTI (23). Therefore, we hypothesized that the improved 
bacterial clearance in macrophage-depleted mice may be due to 
increased infiltration of inflammatory cells, such as neutrophils. At 
24 hours after challenge infection, we observed that, while the 
numbers of resident macrophage subsets, MHCII+ monocytes, and 
MHCII− monocytes in macrophage-depleted mice were reduced 
compared to mock-treated mice, as expected, the numbers of infil-
trating neutrophils were unchanged by antibody treatment (Fig. 6E 
and fig. S6C, gating strategy). Fewer eosinophils infiltrated the 
tissue in macrophage-depleted mice, although the impact of this is 
unclear as their role in infection is unknown (Fig. 6E). Given that 
neutrophil infiltration was unchanged and that monocytes, which 
also take up a large number of bacteria during infection, were re-
duced in number, we considered that improved bacterial clearance 
in macrophage-depleted mice may be due to increased bacterial 
Fig. 6. Macrophage depletion before challenge infection promotes improved bacterial clearance. (A) Experimental scheme. (B) Efficacy of macrophage subset 
depletion in naïve C57BL/6 mice treated with 500 or 800 g of anti-CSF1R antibody. (C and D) Bacterial burden per bladder 24 hours after challenge in female C57BL/6 
mice infected with UTI89-RFP according to (A) and treated with phosphate-buffered saline (PBS) (mock) or (C) 500 g or (D) 800 g of anti-CSF1R antibody 72 hours before 
being challenged with the isogenic UTI89-GFP strain. (E to G) Mice were infected according to (A) and treated with 800 g of anti-CSF1R antibody 72 hours before 
challenge infection with 107 CFU of the isogenic UTI89-GFP strain. Graphs depict the (E) total number of the indicated cell type, (F) the percentage of the indicated cell 
type that was infected, and (G) the total number of the indicated cell type that contained UPEC at 24 hours after challenge in mice treated with PBS or 800 g of anti-CSF1R 
antibody. Data are pooled from three experiments, n = 3 to 6 mice per experiment. Each dot represents one mouse; lines are medians. (C to G) Mann-Whitney test, P values 
were corrected for multiple testing using the FDR method. All P values are shown; statistically significant P values (<0.05) are in red.
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uptake on a per-cell basis during challenge infection. However, bac-
terial uptake was not different between depleted and mock-treated 
mice in neutrophils, MHCII+ and MHCII− monocytes, or either 
macrophage subset (Fig. 6F). The lower numbers of the MacM sub-
set in macrophage-depleted mice translated to lower numbers of 
infected MacM macrophages (Fig. 6, E and G, respectively). How-
ever, we observed no differences in the numbers of infected MacL 
macrophages, neutrophils, and MHCII+ or MHCII− monocytes 
in macrophage-depleted mice compared to nondepleted animals 
(Fig. 6G). Together, these results support the notion that MacM 
macrophages negatively affect bacterial clearance in a challenge infection, 
but not at the level of direct bacterial uptake or myeloid cell infiltration.
Depleting macrophages leads to a TH1-biased immune 
response during challenge infection
As infiltration of inflammatory cells or the number of infected cells 
during challenge infection was not changed in macrophage-depleted 
mice, we questioned whether another host mechanism was involved 
in bacterial clearance. Exfoliation of infected urothelial cells is a 
host mechanism to eliminate bacteria (70, 75). We hypothesized 
that macrophage-depleted mice have increased urothelial exfolia-
tion during challenge infection, leading to reduced bacterial num-
bers. We quantified the mean fluorescence intensity of uroplakins, 
proteins expressed by terminally differentiated urothelial cells (76), 
from bladders of post-challenged mice, depleted of macrophages or 
not (Fig. 7A). We did not detect a significant difference in urotheli-
al exfoliation between mock-treated animals and mice depleted of 
macrophage before challenge infection, supporting that urothelial 
exfoliation is not the underlying mechanism behind improved bac-
terial clearance in macrophage-depleted mice (Fig. 7B). Infiltration 
of inflammatory cells is associated with bladder tissue damage and 
increased bacterial burden (26). As we observed fewer monocytes 
and eosinophils in macrophage-depleted mice during challenge in-
fection, we investigated whether reduced cell infiltration was asso-
ciated with less tissue damage. We assessed edema formation by 
quantifying the area of the lamina propria in post-challenged blad-
ders, depleted of macrophages or not (Fig. 7A). We did not detect a 
difference in edema formation between nondepleted mice and mice 
depleted of macrophage before challenge infection (Fig. 7C).
As we observed fewer eosinophils in macrophage-depleted mice 
during challenge infection, and our previous work demonstrated 
that type 2 immune response–related cytokines are expressed early 
in UTI (24), we assessed the polarity of the T cell response to chal-
lenge infection (fig. S7, gating strategy). Macrophage depletion did 
not alter the infiltration of T regulatory cells or TH2 or TH17 T help-
er subsets (Fig. 7D). However, macrophage depletion did correlate 
with an increase in the numbers of TH1 T cells, NKT cells, NK cells, 
and type 1 innate lymphoid cells (ILC1s) (Fig. 7E). In macrophage- 
depleted mice, TH1 T cells, NKT cells, and NK cells had higher IFN- 
production compared to mock-treated mice (Fig. 7F), suggesting that, 
in the absence of post-infected macrophages, a more pro- inflammatory, 
bactericidal response to challenge infection arises in the bladder.
DISCUSSION
Despite numerous studies of macrophage ontogeny and function in 
many organs, the developmental origin and role of bladder macro-
phages are largely unknown. Here, we investigated this poorly un-
derstood compartment in homeostasis and a highly inflammatory 
infectious disease, UTI. A single macrophage population of yolk sac 
and HSC origin seeds the developing bladder; however, the yolk sac 
macrophage pool is ultimately replaced at some point after birth. 
After birth, two subsets, MacM and MacL, arise in the tissue, local-
izing to the muscle and the lamina propria, respectively. These sub-
sets share similar developmental origin, in that they are primarily 
HSC-derived and, in adulthood, display a very slow turnover by 
Ly6C+ monocytes in the steady state. Their distinct transcriptomics 
support the idea that they play different roles in the bladder, at least 
in the context of infection. The MacM subset is poised to take up 
bacteria or potentially infected dying host cells, while polarizing to-
ward a more alternatively activated profile during UTI. MacL mac-
rophages express a profile with greater potential for the induction of 
inflammation and, whether due to direct consequences of this in-
flammation or potentially due to loss of the urothelium, undergo 
pronounced cell death during UTI.
In adult animals, steady-state tissue-resident macrophages are a 
mix of embryonic and adult monocyte-derived macrophages, with 
the exception of brain microglia (8,  14). The contributions from 
embryonic macrophages and circulating adult monocytes to the 
adult bladder macrophage compartment are similar to that of the 
lung and kidney (7, 11, 77). Although two macrophage subsets re-
side in the adult bladder, only a single LYVE1+CX3CR1+ macrophage 
population was identified in embryonic and newborn bladders. 
As the bladder is fully formed in newborn mice (78), it is unlikely 
that macrophage subsets arise to meet the needs of a new struc-
ture, as is the case for peritubular macrophages in the testis (41). 
Rather, although all structures are present, embryonic or prenatal 
bladder tissue demands are likely distinct from postnatal tissue re-
modeling in very young mice. For example, in the first weeks after 
birth, bladder macrophages may support urothelial cells under-
going increased proliferation to establish the three layers of urothelium 
in adult bladders (79). As these adult tissue niches become fully 
mature, they may provide different growth or survival factors, driv-
ing functional macrophage specialization in discrete locations in 
the tissue.
In the lung, spleen, BM, and liver, a subpopulation of pro-resolving 
macrophages are present that phagocytize blood-borne cellular ma-
terial to maintain tissue homeostasis (66). These macrophages ex-
press Mrc1 (encoding for CD206), CD163, and Timd4 (encoding 
TIM4) (66). MacM macrophages likely represent this subpopulation 
in the bladder, as they expressed higher levels of genes associated 
with a pro-resolving phenotype, including the efferocytic receptor 
TIM4, CD206, and CD163. It is also possible that, similar to muscu-
laris macrophages in the gut, MacM macrophages interact with 
neurons to control muscle contraction in the bladder and limit neu-
ronal damage during infection (80, 81). By contrast, up-regulated 
pathways in the MacL subset, in combination with their localization 
under the urothelium, suggest that, similar to intestinal macro-
phages, they may regulate T cell responses to bladder microbiota or 
support urothelial cell integrity (82, 83).
Although it was somewhat unexpected, given that the MacM 
macrophage subset is located farther from the lumen and urotheli-
um, where infection takes place, we favor the conclusion that MacM 
macrophages contain more bacteria because they are programmed 
to do so. This conclusion is supported by the higher expression of 
genes associated with complement, endocytosis, and phagosome pathways 
in the MacM subset. It is possible, although challenging to empirically 
demonstrate, that the MacM subset recognizes dying neutrophils, 
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Fig. 7. Depletion of replaced macrophages leads to a type I immune bias. Female C57BL/6 mice were infected according to the scheme shown in Fig. 6A and treated 
with 800 g of anti-CSF1R antibody 72 hours before challenge infection with 107 CFU of UTI89. (A) Representative confocal images of bladders from mice treated with PBS 
or 800 g of anti-CSF1R antibody 24 hours after challenge. Uroplakin, green; phalloidin, turquoise; DAPI, blue. (B) The graph shows the mean fluorescence intensity of 
uroplakin expression, quantified from imaging, at 24 hours after challenge. (C) The graph shows the area of the lamina propria, quantified from imaging, at 24 hours after 
challenge. (D to F) Graphs depict the (D and E) total number of the indicated cell type or (F) the total number of the indicated cell type expressing IFN- at 24 hours after 
challenge infection. Data are pooled from two experiments, n = 4 to 6 mice per experiment. Each dot represents one mouse; lines are medians. In (B) to (F), significance 
was determined using the nonparametric Mann-Whitney test and P values were corrected for multiple testing using the FDR method. All calculated/corrected P values 
are shown and P values meeting the criteria for statistical significance (P < 0.05) are depicted in red.
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or even dying MacL macrophages, that have phagocytosed bacteria. 
We may also consider that, between the subsets, the rate at which 
bacteria are killed is different, UPEC may survive better in MacM 
macrophages, MacL macrophages may die after bacterial uptake, 
the near-luminal location of MacL macrophages may result in their 
disproportionate sloughing, or even that MacL macrophages break 
down phagocytosed content better. Additional genetic and knock-
out models would be needed to address these possibilities.
Significant numbers of MacL macrophages died in the first 
hours following infection, reflecting their enriched apoptosis path-
way. The reduced numbers of both macrophage subsets in prota-
mine sulfate-treated mice suggest that alterations in the urothelium 
may affect macrophage survival, although we cannot rule out the 
fact that protamine sulfate directly kills macrophages. Exfoliation 
induced by protamine sulfate is not comparable to infection, as pro-
tamine sulfate induces a rapid, large increase in trans-urothelial 
conductance (71), suggesting that it induces major disruptions in 
the urothelium. Protamine sulfate can also suppress cytokine activ-
ity and the inflammatory response in the bladder compared to 
UPEC infection (84). This severe disruption of the urothelium may 
lead to inadequate supplies of oxygen, nutrients, or survival factors, 
all of which would be detrimental to macrophage survival. It is less 
likely that bacteria induce macrophage death as only a small, and 
importantly equivalent, proportion of both subsets were infected. 
Instead, MacL macrophage death may be an important step to initi-
ate immune responses to UTI. In the liver, Kupffer cell death by 
necroptosis during Listeria monocytogenes infection induces re-
cruitment of monocytes, which, in turn, phagocytose bacteria (85). 
Here, macrophage depletion before challenge infection resulted in 
decreased infiltration of monocytes, likely due to diminished num-
bers of these cells in circulation, and fewer eosinophils; however, 
bacterial burden was also decreased. This suggests that macrophage- 
mediated immune cell recruitment is not their primary function in 
the bladder. Infiltration of inflammatory cells is not the only way 
macrophage cell death regulates infection, however. For instance, 
pyroptotic macrophages can entrap live bacteria and facilitate their 
elimination by neutrophils in vivo (86). As MacM macrophages ex-
press genes regulating iron metabolism, limiting iron to UPEC would 
also be a plausible mechanism to control bacterial growth (87).
In the steady state, tissue-resident macrophages can self-maintain 
locally by proliferation, with minimal input of circulating mono-
cytes (9, 88). By contrast, under inflammatory conditions, resident 
macrophages are often replaced by monocyte-derived macrophages 
(85, 88–90). Monocytes will differentiate into self-renewing func-
tional macrophages if the endogenous tissue-resident macrophages 
are depleted or are absent (91, 92). Our results show that UPEC in-
fection induces sufficient inflammation to foster infiltration and 
differentiation of newly recruited monocytes. It is likely, even, that 
greater macrophage replacement occurs than we actually measured, 
as we used a single 4OHT pulse in CCR2CreERT2 Rosa26tdTomato mice 
24 hours before infection; however, these cells infiltrate infected 
bladders over several days. These experiments do not rule out a role 
for local proliferation in the bladder during UTI, but experiments to 
test this must be able to distinguish infiltrated monocytes that have 
already differentiated into tissue macrophages from bona fide tissue- 
resident macrophages when assessing proliferating cells. These data 
do support, however, the fact that infiltrating monocytes remain in 
the tissue, integrated into the resident macrophage pool, after tissue 
resolution.
Recruited monocyte-derived macrophages can behave differently 
than resident macrophages when activated, such as in the lung. 
Gamma herpes virus induces alveolar macrophage replacement by 
“regulatory” monocytes expressing higher levels of Sca-1 and MHC 
II (93). These post-infected mice have reduced perivascular and 
peribronchial inflammation and inflammatory cytokines, and fewer 
eosinophils compared to mock-infected mice when exposed to 
house dust mite to induce allergic asthma (93). Alveolar macro-
phages of mice infected with influenza virus are replaced by pro- 
inflammatory monocyte-derived macrophages. At 30 days PI, 
influenza-infected mice have more alveolar macrophages and increased 
production of IL-6 when challenged with S. pneumoniae compared 
to mock-infected mice, leading to fewer deaths (90). Although 
mechanisms regulating the phenotype of monocyte-derived macro-
phages are not known, the time of residency in the tissue and the 
nature of subsequent insults likely influence these cells. The longer 
that recruited macrophages reside in tissue, the more similar they 
become to tissue-resident macrophages and no longer provide en-
hanced protection to subsequent tissue injury (89, 90). In contrast 
to these studies in the lung, we found that elimination of macro-
phages, including those recruited during primary infection, led to 
improved bacterial clearance during secondary challenge, although 
it is not clear what the long-term consequences on bladder homeo-
stasis might be when a more inflammatory type 1 immune response 
arises during infection.
Overall, our results demonstrate that two unique subsets of mac-
rophages reside in the bladder. During UTI, these cells respond dif-
ferently, and a proportion of the population dies. Thus, a first UPEC 
infection induces replacement of resident macrophage subsets by 
monocyte-derived cells. When sufficient numbers of MacM macro-
phages, composed of resident and replaced cells, are depleted, im-
proved bacterial clearance follows, suggesting a major role of this 
subset in directing the immune response to challenge infection. 
While these findings greatly improve our understanding of this im-
portant immune cell type, much remains to be uncovered, such as 
the signals and niches that contribute to the establishment of two 
subsets of bladder-resident macrophages, their roles in the estab-
lishment and maintenance of homeostasis, and whether parallel 
populations and functions exist in human bladder tissue.
MATERIALS AND METHODS
Study design
This study was conducted using a preclinical mouse model and 
transgenic mouse strains in controlled laboratory experiments to 
investigate the origin, maintenance, and function of bladder-resident 
macrophages in homeostasis and bacterial infection. At the onset of 
this study, our objective was to understand how bladder-resident 
macrophages negatively affect the development of adaptive immu-
nity to UTI. Having found two resident macrophage subsets in the 
course of this work, our objectives were to determine whether these 
subsets have similar origins and homeostatic maintenance and 
whether they play divergent roles in response to primary or chal-
lenge infection. Mice were assigned to groups upon random parti-
tion into cages. In all experiments, a minimum of 2 and a maximum 
of 10 mice (and more typically 3 to 6 mice per experiment) made up 
an experimental group and all experiments were repeated two to 
three times. Sample size was based on our previous work and was 
not changed in the course of the study. In some cases, n was limited 
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by the number of developing embryos available from timed preg-
nancies. Data collection is detailed below. Data from all repetitions 
were pooled before any statistical analysis. As determined a priori, 
all animals with abnormal kidneys (atrophied, enlarged, and white 
in color) at the time of sacrifice were excluded from all analyses, as 
we have observed that abnormal kidneys negatively affect resolution 
of infection. End points were determined before the start of experi-
ments and researchers were not blinded to experimental groups.
Mice and ethical approvals
All animals used in this study had free access to standard laboratory 
chow and water at all times. We used female C57BL/6J mice 7 to 
8 weeks old from Charles River, France. Female CX3CR1GFP/+ mice 
7 to 8 weeks old were bred in-house. CX3CR1GFP/GFP mice, used to 
maintain our hemizygous colony, were a gift from F. Chretien 
(Institut Pasteur). Cdh5-CreERT2 Rosa26tdTomato mice were crossed 
to CX3CR1GFP mice, producing Cdh5-CreERT2.Rosa26tdTomato.
CX3CR1GFP mice at Centre d’Immunologie de Marseille-Luminy. 
In Cdh5-CreERT2.Rosa26tdTomato.CX3CR1GFP mice, cells express-
ing the CX3CR1 receptor are constitutively GFP+, and treatment 
with 4OHT conditionally labels hemogenically active endothelial 
cells (42). We used female and male Cdh5-CreERT2.Rosa26tdTomato.
CX3CR1GFP mice 8 to 11 weeks old, at E16.5, and newborns. Flt3Cre.
Rosa26YFP mice were a gift from E.G.P. (Institut Pasteur). CCR2−/− mice 
were a gift from M. Lecuit (Institut Pasteur). CCR2creERT2BB mice were 
a gift from B. Becher (University of Zurich) via S. Amigorena (Institut 
Curie). CCR2creERT2BB male mice were crossed to Rosa26tdTomato 
females to obtain CCR2creERT2BB- tdTomato mice at Institut Pasteur. 
We used female CCR2creERT2BB- tdTomato mice 7 to 8 weeks old. 
Additional details of the mouse strains used, including JAX and 
MGI numbers, are listed in table S1. Mice were anesthetized by 
injection of ketamine (100 mg/kg) and xylazine (5 mg/kg) and 
euthanized by carbon dioxide inhalation. Experiments were con-
ducted at Institut Pasteur in accordance with approval of protocol 
number 2016-0010 and dha190501 by the Comité d’éthique en 
expérimentation animale Paris Centre et Sud (the ethics committee 
for animal experimentation), in application of the European Direc-
tive 2010/63 EU. Experiments with Cdh5-CreERT2 mice were per-
formed in the laboratory of M. Bajenoff, Centre d’Immunologie de 
Marseille- Luminy, in accordance with national and regional guide-
lines under protocol number 5-01022012 following review and ap-
proval by the local animal ethics committee in Marseille, France.
Reagents and software
Antibodies, reagents, and software used in this study are listed in 
tables S2, S3, and S4, respectively.
Flow cytometry of bladder tissue and blood
Samples were acquired on a BD LSRFortessa using DIVA software 
(v8.0.1), and data were analyzed by FlowJo (Treestar) software, in-
cluding the plugins for downsampling, tSNE, and UMAP (version 
10.0). The analysis of bladder and blood was performed as described 
previously (23). Briefly, bladders were dissected and digested in 
buffer containing Liberase (0.34 U/ml) in phosphate-buffered 
saline (PBS) at 37°C for 1 hour with manual agitation every 15 min. 
Digestion was stopped by adding PBS supplemented with 2% fetal 
bovine serum (FBS) and 0.2 M EDTA [fluorescence-activated cell 
sorting (FACS) buffer]. Fc receptors in single-cell suspensions were 
blocked with anti-mouse CD16/CD32 and stained with antibodies. 
Total cell counts were determined by addition of AccuCheck counting 
beads to a known volume of sample after staining, just before cytometer 
acquisition. To determine cell populations in the circulation, whole blood 
was incubated with BD PharmLyse and stained with antibodies (table S2). 
Total cell counts were determined by the addition of AccuCheck count-
ing beads to 10 l of whole blood in 1-step Fix/Lyse Solution.
For intracellular staining, single-cell suspensions were resus-
pended in 1 ml of Golgi stop protein transport inhibitor, diluted 
(1:1500) in RPMI with 10% FBS, 1% sodium pyruvate, 1× Hepes, 
1× nonessential amino acid, 1% penicillin-streptomycin, phorbol 
12-myristate 13-acetate (50 ng/ml), and ionomycin (1 g/ml), and 
incubated for 4 hours at 37°C. Samples were washed once with 
FACS buffer, and Fc receptors blocked with anti-mouse CD16/
CD32. Samples were stained with antibodies listed in table S2 
against surface markers and fixed and permeabilized with 1× fixa-
tion and permeabilization buffer and incubated at 4°C for 40 to 
50 min protected from light. After incubation, samples were washed 
two times with 1× permeabilization and wash buffer from the tran-
scription factor buffer kit and stained with antibodies against IFN- 
and the transcriptional factors RORT, GATA3, T-bet, and FoxP3 
(table S2), diluted in 1× permeabilization and wash buffer at 4°C for 
40 to 50 min protected from light. Last, samples were washed two 
times with 1× permeabilization and wash buffer and resuspended in 
FACS buffer. Total cell counts were determined by addition of 
counting beads to a known volume of sample after staining, just 
before cytometer acquisition.
Histological and immunostaining for confocal microscopy
Whole bladders were fixed with 4% paraformaldehyde (PFA) in PBS 
for 1 hour and subsequently washed with PBS. Samples were then 
dehydrated in 30% sucrose in PBS for 24 hours. Samples were cut 
transversally and embedded in optimal cutting temperature com-
pound, frozen, and sectioned at 30 m. Sections were blocked for 
1 hour with blocking buffer [3% bovine serum albumin (BSA) + 0.1% 
Triton X-100 + donkey serum (1:20) in PBS] and washed three 
times. Immunostaining was performed using F4/80, LYVE1 anti-
bodies, or polyclonal “asymmetrical unit membrane” antibodies, 
recognizing uroplakins [gift from X.-R. Wu, NYU School of Medicine, 
(76)] (1:200) in staining buffer (0.5% BSA + 0.1% Triton X-100 in PBS) 
overnight. Sections were washed and stained with phalloidin (1:350) 
and secondary antibodies (1:2000) in staining buffer for 4 hours. 
Last, sections were washed and stained with 4′,6-diamidino-2- 
phenylindole. Confocal images were acquired on a Leica SP8 confocal 
microscope. Final image processing was done using Fiji (version 
2.0.0-rc-69/1.52p) and Icy software (v1.8.6.0).
Timed pregnancies and in utero tamoxifen administration
Fate mapping of Cdh5-CreERT2 mice was performed as described 
previously (42). Briefly, for reporter recombination in offspring, a 
single dose of 4OHT supplemented with progesterone (1.2 mg of 
4OHT and 0.6 mg of progesterone) was delivered by intraperitoneal 
injection to pregnant females at E7.5 or E10.5. Progesterone was 
used to counteract adverse effects of 4OHT on pregnancies. To fate 
map cells in CCR2creERT2BB-tdTomato mice, a single dose (37.5 g/g) 
of 4OHT injection was delivered intraperitoneally.
Shielded BM chimeras
For shielded irradiation, 7- to 8-week-old wild-type female CD45.1 
or CD45.2 C57BL6/J mice were anesthetized and dressed in a 
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lab-made lead diaper, which selectively exposed their tail, legs, 
torso, and head to irradiation, but protected the lower abdomen, 
including the bladder. Mice were irradiated with 9 gray from an 
Xstrahl x-ray generator (250 kV, 12 mA) and reconstituted with 
~3 × 107 to 4 × 107 BM cells isolated from congenic (CD45.1) wild-
type mice or CD45.2 CCR2−/− mice.
RNA-seq and bioinformatic analyses
Samples were obtained from the whole bladders of naïve and 6-week 
post-infected female C57BL/6J mice. Using FACS, four separate 
sorts were performed to generate biological replicates, and each sort 
was a pool of 10 mouse bladders. Macrophage subsets were FACS- 
purified into 350 l of RLT Plus buffer from the RNeasy Micro Kit 
plus (1:100) -mercaptoethanol. Total RNA was extracted using 
the RNeasy Micro Kit following the manufacturer’s instructions. 
Directional libraries were prepared using the Smarter Stranded Total 
RNA-Seq kit Pico Input Mammalian following the manufacturer’s 
instructions. The quality of libraries was assessed with the DNA-
1000 kit on a 2100 Bioanalyzer, and quantification was performed 
with Quant-It assays on a Qubit 3.0 fluorometer. Clusters were gen-
erated for the resulting libraries with Illumina HiSeq SR Cluster 
Kit v4 reagents. Sequencing was performed with the Illumina HiSeq 
2500 system and HiSeq SBS kit v4 reagents. Runs were carried out 
over 65 cycles, including seven indexing cycles, to obtain 65-bp 
single- end reads. Sequencing data were processed with Illumina 
Pipeline software (Casava version 1.9). Reads were cleaned of adapter 
sequences and low-quality sequences using cutadapt version 1.11. 
Only sequences of at least 25 nucleotides in length were considered 
for further analysis, and the five first bases were trimmed following 
the library manufacturer’s instructions. STAR version 2.5.0a (94), 
with default parameters, was used for alignment on the reference 
genome (Mus musculus GRCm38_87 from Ensembl version 87). 
Genes were counted using featureCounts version 1.4.6-p3 (95) from 
Subreads package (parameters: -t exon -g gene_id -s 1). Count data 
were analyzed using R version 3.4.3 and the Bioconductor package 
DESeq2 version 1.18.1 (96). The normalization and dispersion esti-
mation were performed with DESeq2 using the default parameters, 
and statistical tests for differential expression were performed applying 
the independent filtering algorithm. A generalized linear model was 
set to test for the differential expression among the four biological 
conditions. For each pairwise comparison, raw P values were adjusted 
for multiple testing according to the Benjamini and Hochberg proce-
dure and genes with an adjusted P value lower than 0.05 were con-
sidered differentially expressed. Count data were transformed using 
variance stabilizing transformation to perform samples clustering 
and PCA plot. The PCA was performed on the variance-stabilized 
transformed count matrix that was adjusted for the batch/replicate 
effect using the limma R package version 3.44.3.
To perform pathway analysis, gene lists of DEGs were imported 
in the Cytoscape software (version 3.7.2), and analyses were per-
formed using the ClueGO application with the Kyoto Encyclopedia 
of Genes and Genomes as the database. Significant pathways were 
selected using the threshold criteria Q < 0.05; terms > 3 genes; % 
genes/term > 3;  0.4.
Bacterial strains and infection
We used the human UPEC cystitis isolate UTI89 engineered to ex-
press the fluorescent proteins RFP or GFP and antibiotic-resistant 
cassettes to either kanamycin (UPEC-RFP) or ampicillin (UPEC- 
GFP) to infect animals for flow cytometric and bacterial burden 
analyses (23). We used the nonfluorescent parental strain UTI89 for 
confocal imaging experiments and flow cytometric experiments 
with CCR2CreERT2 Rosa26tdTomato mice (97). To allow expression of 
type 1 pili, necessary for infection (98), bacteria cultures were grown 
statically in Luria-Bertani broth medium for 18 hours at 37°C in 
the presence of antibiotics [kanamycin (50 g/ml) or ampicillin 
(100 g/ml)]. Primary and challenge UTI were induced in mice as 
previously described (23,  99). For challenge infection, urine was 
collected twice a week, for 4 weeks, to follow the presence of bacteria 
in the urine. Once there were no UTI89-RFP bacteria in the urine, 
mice were challenged with UTI89-GFP bacteria and euthanized 
24 hours after challenge infection. To calculate CFU, bladders were 
aseptically removed and homogenized in 1 ml of PBS. Serial dilu-
tions were plated on LB agar plates with antibiotics, as required. For 
in vitro infections, macrophage subsets were sorted from a pool of 
10 bladders of naïve female C57BL/6J 7- to 8-week-old mice us-
ing FACS and 2 × 103 cells were incubated with 2 × 104 CFU of 
UPEC-RFP for 2 hours at 37°C. Cells were acquired on a BD LSR-
Fortessa using DIVA software (v8.0.1) and data were analyzed by 
FlowJo (Treestar) software (version 10.0).
Protamine sulfate administration
Seven- to 8-week-old wild-type female C57BL6/J mice were anes-
thetized and instilled intravesically with 50 l of protamine sulfate 
(50 mg/ml) diluted in PBS and euthanized 5 hours after instillation 
for analysis.
Immune cell depletion
To produce anti-CSF1R antibody, the hybridoma cell line AFS98 
(gift from M. Merad at Icahn School of Medicine at Mount Sinai) 
(100) was cultured in disposable reactor cell culture flasks for 14 days, 
and antibodies were purified with disposable PD10 desalting col-
umns. To deplete macrophages, wild-type C57BL/6 mice received 
intravenous injection of anti-CSF1R antibody (2 mg/ml) diluted 
in PBS. Animals received two or three intravenous injections, on 
consecutive days, of anti-CSF1R antibody or PBS. To deplete macro-
phages with a final concentration of 500 g of anti-CSF1R, we ad-
ministered 250 g per mouse on day 1 and 250 g per mouse on day 
2. To deplete macrophages with a final concentration of 800 g of 
anti-CSF1R, we administered 400 g per mouse on day 1, 200 g per 
mouse on day 2, and 200 g per mouse on day 3 to minimize the 
impact on circulating monocytes.
Quantification of macrophage subsets, urothelial 
exfoliation, and tissue edema
To quantify macrophage subsets in bladder tissue, six to seven im-
ages were randomly acquired of each of the areas of the muscle and 
lamina propria per mouse in wild-type C57BL/6 female mice with 
40× magnification in an SP8 Leica microscope. Maximum intensity 
Z-projections were performed, and macrophage subsets were counted 
using Icy software (v1.8.6.0). To quantify urothelial exfoliation and 
tissue edema, images from whole bladder cross sections were 
acquired using 20× magnification in an SP8 Leica microscope. 
Maximum intensity Z-projections were performed, the urothelium 
was delimited, and mean fluorescence intensity of uroplakin stain-
ing was measured using Fiji (v1.51j) software. To quantify tissue 
edema, the lamina propria was delimited and the area was measured 
using Fiji software (v1.51j).
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Statistical analysis
Statistical analysis was performed in GraphPad Prism 8 (GraphPad, 
USA) for Mac OS X applying the nonparametric Wilcoxon test for 
paired data or the nonparametric Mann-Whitney test for unpaired 
data in the case of two group comparisons. In the case that more 
than two groups were being compared or to correct for compari-
sons made within an entire analysis or experiment, calculated P values 
were corrected for multiple testing with the false discovery rate 
(FDR) method (https://jboussier.shinyapps.io/MultipleTesting/) to 
determine the FDR-adjusted P value. All calculated P values are 
shown in the figures, and those that met the criteria for statistical 
significance (P < 0.05) are denoted with red text.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/6/48/eabc5739/DC1
View/request a protocol for this paper from Bio-protocol.
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